What is the current Hyperthermia Therapy for Cancer market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Hyperthermia Therapy for Cancer market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Hyperthermia Therapy for Cancer market?

Increasing cancer incidence and technological advancements are key drivers.

What are the major challenges facing the Hyperthermia Therapy for Cancer market?

High treatment costs and limited awareness are significant challenges.

Which regions are leading the Hyperthermia Therapy for Cancer market?

North America and Europe are currently leading the market.

Who are the top companies in the Hyperthermia Therapy for Cancer market?

Major players include Pyrexar Medical and Celsius42.

What are the future opportunities in the Hyperthermia Therapy for Cancer market?

Emerging markets and innovative technologies offer future opportunities.

How will technology impact the Hyperthermia Therapy for Cancer market?

Advances in thermal monitoring and imaging will enhance treatment outcomes.

What is the current regulatory landscape for the Hyperthermia Therapy for Cancer market?

Regulatory frameworks vary by region, with ongoing updates and revisions.

What is the future outlook for the Hyperthermia Therapy for Cancer market?

The market is expected to experience significant growth due to increasing demand.

What Is the Global Hyperthermia Therapy for Cancer Market Worth in 2026?

Hyperthermia Therapy for Cancer by Application (Breast Cancer, Cervical Cancer, Soft Tissue Sarcoma, Melanoma, Others), by Types (Superficial Hyperthermia, Deep Regional Hyperthermia), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 126

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 126

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Hyperthermia Therapy for Cancer Market Size | CAGR 12.8 Forecast 2033

What Is the Global Hyperthermia Therapy for Cancer Market Worth in 2026?

🏭 Healthcare🌍 Global

Pages: 126

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 126

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Hyperthermia Therapy for Cancer Market Overview

Hyperthermia Therapy for Cancer is a minimally invasive treatment that uses heat to destroy cancer cells. The Hyperthermia Therapy for Cancer market size is estimated to be around $173 million in 2025, with a growth outlook that is expected to drive the market forward. As the demand for effective cancer treatments continues to rise, the market forecast suggests a significant expansion of the industry, with a compound annual growth rate (CAGR) of 17.2% during the forecast period from 2026 to 2033. The industry expansion will be driven by advances in technology, increasing awareness about the benefits of hyperthermia therapy, and a growing patient population.

Loading chart…

The Hyperthermia Therapy for Cancer market is expected to be shaped by several key forces, including technology shifts towards more targeted and efficient treatments, regulatory developments that support the adoption of hyperthermia therapy, and consumer behavior that increasingly favors minimally invasive and non-toxic treatments. The largest region for hyperthermia therapy is currently North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing investment in healthcare infrastructure and a growing awareness about the benefits of hyperthermia therapy.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.15 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Pyrexar Medical; Oncotherm; Andromedic; Yamamoto Vinita; Med-Logix; Thermofield; Celsius42; Dongseo Medicare; ThermaSolutions; Verthermia; Combat Medical; Hydrosun; RanD Biotech; Shenzhen ET Medical Technology; Jiangsu Nova Medical Equipment
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Hyperthermia Therapy for Cancer market is poised for significant growth, driven by increasing cancer incidence rates and rising demand for non-invasive treatments. The Hyperthermia Therapy for Cancer market size is expected to expand substantially, with a promising growth forecast.

Growth Drivers2 items

Advances in thermal dosimetry and imaging technologies are enhancing the precision and efficacy of Hyperthermia Therapy for Cancer, thereby driving adoption rates among oncologists and patients alike.

The growing popularity of combination therapies, where Hyperthermia Therapy for Cancer is used in conjunction with chemotherapy, radiation, or immunotherapy, is also contributing to the market's upward trajectory.

Restraints2 items

High equipment costs and limited reimbursement coverage for Hyperthermia Therapy for Cancer procedures are constraining market growth, particularly in resource-constrained healthcare settings.

The lack of standardization in treatment protocols and clinical guidelines is also hindering the widespread adoption of Hyperthermia Therapy for Cancer, as healthcare providers may be hesitant to invest in unproven technologies.

Opportunities2 items

Emerging markets, such as Asia-Pacific and Latin America, offer significant growth opportunities for Hyperthermia Therapy for Cancer vendors, driven by rising cancer prevalence and increasing healthcare expenditure.

The development of portable and affordable Hyperthermia Therapy for Cancer systems is expected to expand the market's reach, enabling greater access to care for patients in remote or underserved areas.

Challenges2 items

Intense competition among Hyperthermia Therapy for Cancer vendors is driving down prices and profit margins, making it challenging for companies to sustain their market position and invest in research and development.

The need for specialized training and technical expertise to operate Hyperthermia Therapy for Cancer equipment is a significant barrier to adoption, particularly in healthcare settings with limited resources or expertise.

Market Segmentation

Loading chart…

The Hyperthermia Therapy for Cancer segmentation by Application includes various cancer types such as breast cancer, lung cancer, prostate cancer, and others. This segmentation contributes to the overall market size by providing insights into the specific areas where hyperthermia therapy is most effective. According to industry-reporting standards, the application segment is a crucial aspect of the Hyperthermia Therapy for Cancer market taxonomy.

The Types segment of the Hyperthermia Therapy for Cancer market includes subtypes such as local hyperthermia, regional hyperthermia, and whole-body hyperthermia. Each subtype has its own unique characteristics and applications, contributing to the overall market size. Understanding these subtypes is essential for analyzing the market taxonomy and identifying trends in the Hyperthermia Therapy for Cancer market.

Hyperthermia Therapy for Cancer Segmentation Breakdown9 items

Application

Breast Cancer

Cervical Cancer

Soft Tissue Sarcoma

Melanoma

Others

Types

Superficial Hyperthermia

Deep Regional Hyperthermia

Regional Insights

Loading chart…

The Hyperthermia Therapy for Cancer market growth is expected to vary across regions, with the largest region being North America, accounting for approximately 40% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of hyperthermia therapy, favorable policies, and significant investments in healthcare infrastructure. Key drivers for North America include a mature ecosystem, high demographics awareness, and established infrastructure.

In Europe, key drivers include regional forecast indicating a growing demand for cancer treatments, increasing investments in research and development, and a rising adoption of advanced therapies. Asia Pacific's growth is further fueled by a large and growing demographics, increasing infrastructure development, and rising ecosystem maturity. Latin America and Middle East & Africa are expected to experience steady growth, driven by improving policies, growing adoption, and expanding infrastructure.

The Hyperthermia Therapy for Cancer market is poised for significant growth, with each region presenting unique opportunities and challenges. Understanding the key drivers and trends in each region is crucial for stakeholders to navigate the market effectively and capitalize on emerging opportunities, ultimately contributing to the regional forecast and Hyperthermia Therapy for Cancer market growth.

Competitive Landscape

The Hyperthermia Therapy for Cancer market is moderately consolidated, driven by a mix of global players and local companies. The Hyperthermia Therapy for Cancer competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on technological advancements and strategic partnerships to maintain their market position, while local companies emphasize regional expansion and cost advantages.

Companies in this market employ various strategies, including M&A, partnerships, product launches, expansion, R&D, and localization, to differentiate themselves. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. To stay competitive, companies must focus on innovative technologies, service models, and channel strength. The following companies have distinct strategic focuses:

Pyrexar Medical: regional expansion

Oncotherm: innovation pipeline

Andromedic: premium pricing

Yamamoto Vinita: local manufacturing

Med-Logix: OEM tie-ups

Thermofield: vertical integration

Key Hyperthermia Therapy for Cancer Companies15 items

Pyrexar Medical

Oncotherm

Andromedic

Yamamoto Vinita

Med-Logix

Thermofield

Celsius42

Dongseo Medicare

ThermaSolutions

Verthermia

Combat Medical

Hydrosun

RanD Biotech

Shenzhen ET Medical Technology

Jiangsu Nova Medical Equipment

Market Ecosystem

The Hyperthermia Therapy for Cancer ecosystem encompasses a complex network of upstream, midstream, and downstream participants, including technology providers, integrators, channels, and end users. Value is created and captured as these entities interact to develop, manufacture, and deliver hyperthermia therapy solutions to cancer patients. The ecosystem boundaries stretch from raw material and component suppliers to end users, with various intermediaries playing crucial roles in the value chain analysis.

Raw material/component suppliers — provide essential components

Technology providers — develop hyperthermia therapy technologies

OEMs / manufacturers — design and manufacture hyperthermia devices

System integrators / EPCs — integrate hyperthermia systems

Distributors / channel partners — distribute hyperthermia devices

Service providers / after-sales — offer maintenance and support services

Regulators/standards bodies — establish and enforce safety standards

The flow of value within the Hyperthermia Therapy for Cancer ecosystem is influenced by control points, such as regulatory approvals and reimbursement policies, which can impact adoption rates. Dependency risks, including input constraints and standards compliance, can also affect the ecosystem's functioning. Furthermore, switching costs, partnerships, and interoperability requirements can create barriers to entry or exit. The ecosystem's dynamics can vary by region, with different countries having distinct regulatory frameworks, healthcare systems, and market requirements.

Recent Industry Insights

The Hyperthermia Therapy for Cancer industry has witnessed significant developments over the last 12-18 months, shaping the future of cancer treatment. Recent partnerships, such as collaborations between leading medical institutions and technology firms, have accelerated innovation in the field. Notable mergers and acquisitions have also taken place, further consolidating the market and driving growth. Moreover, several product and technology launches have expanded the range of treatment options available to patients, reflecting the evolving Hyperthermia Therapy for Cancer industry trends.

In addition to these advancements, regulatory changes have played a crucial role in promoting the adoption of hyperthermia therapy. A shift in consumer and enterprise trends towards more targeted and minimally invasive cancer treatments has also fueled demand for hyperthermia therapy. Furthermore, funding rounds and expansions have enabled companies to invest in research and development, leading to improved treatment outcomes and increased accessibility.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Hyperthermia Therapy for Cancer market outlook. The market exhibits moderate attractiveness due to the increasing prevalence of cancer and growing demand for non-invasive treatments. Competitive intensity is relatively low, with few major players dominating the market. The long-term outlook appears promising, driven by advancements in technology and rising awareness about the benefits of hyperthermia therapy. The innovation landscape is characterized by ongoing research into new heating methods and combination therapies.

The demand-supply balance is expected to be stable, with key risk factors including regulatory hurdles and high treatment costs. Despite these challenges, the market is poised for growth, with opportunities for new entrants and established players to expand their offerings. Overall, the Hyperthermia Therapy for Cancer market presents a compelling opportunity for investors and healthcare providers seeking to capitalize on emerging trends in cancer treatment.

12 items

1. Executive Summary

2. Hyperthermia Therapy for Cancer Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Hyperthermia Therapy for Cancer Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Hyperthermia Therapy for Cancer Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Hyperthermia Therapy for Cancer Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Hyperthermia Therapy for Cancer Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Hyperthermia Therapy for Cancer Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Hyperthermia Therapy for Cancer Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Hyperthermia Therapy for Cancer Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Hyperthermia Therapy for Cancer Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Hyperthermia Therapy for Cancer Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Hyperthermia Therapy for Cancer Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Hyperthermia Therapy for Cancer Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Hyperthermia Therapy for Cancer Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Hyperthermia Therapy for Cancer Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Hyperthermia Therapy for Cancer Market Competition by Key Manufacturers

9.1. Global Hyperthermia Therapy for Cancer Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Hyperthermia Therapy for Cancer: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Pyrexar Medical

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Oncotherm

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Andromedic

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Yamamoto Vinita

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Med-Logix

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Thermofield

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Celsius42

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Dongseo Medicare

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. ThermaSolutions

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Verthermia

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Combat Medical

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Hydrosun

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. RanD Biotech

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Shenzhen ET Medical Technology

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Jiangsu Nova Medical Equipment

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Hyperthermia Therapy for Cancer Market

Figure 4: Global Hyperthermia Therapy for Cancer Market: Drivers

Figure 5: Global Hyperthermia Therapy for Cancer Market: Challenges

Figure 6: Global Hyperthermia Therapy for Cancer Market: Trends

Figure 7: Global Hyperthermia Therapy for Cancer Market: Opportunity

Figure 8: Global Hyperthermia Therapy for Cancer Market: Restraint

Figure 9: Global Hyperthermia Therapy for Cancer Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Hyperthermia Therapy for Cancer Market Value (USD Million) By Region

Figure 19: Global Hyperthermia Therapy for Cancer Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Hyperthermia Therapy for Cancer Market Value (USD Million) By Region

Figure 27: Global Hyperthermia Therapy for Cancer Market Share (%) By: Regions (2032)

Figure 28: Global Hyperthermia Therapy for Cancer Market Volume (K) By Region

Figure 29: Global Hyperthermia Therapy for Cancer Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Hyperthermia Therapy for Cancer Market Value (USD Million) By Region

Figure 37: Global Hyperthermia Therapy for Cancer Market Share (%) By: Regions (2032)

Figure 38: Global Hyperthermia Therapy for Cancer Market Volume (K) By Region

Figure 39: Global Hyperthermia Therapy for Cancer Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

125 items

Table 1: Market Segmentation Analysis

Table 2: Global Hyperthermia Therapy for Cancer Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Hyperthermia Therapy for Cancer Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Hyperthermia Therapy for Cancer Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Hyperthermia Therapy for Cancer Market Value (USD Million) By Region

Table 14: Global Hyperthermia Therapy for Cancer Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Hyperthermia Therapy for Cancer Market Volume (K) By Region

Table 31: Global Hyperthermia Therapy for Cancer Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Hyperthermia Therapy for Cancer Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Hyperthermia Therapy for Cancer Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Hyperthermia Therapy for Cancer Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Pyrexar Medical Basic Information And Sales Area

Table 52: Pyrexar Medical. Products Portfolio

Table 53: Oncotherm Basic Information And Sales Area

Table 54: Oncotherm. Products Portfolio

Table 55: Andromedic Basic Information And Sales Area

Table 56: Andromedic. Products Portfolio

Table 57: Yamamoto Vinita Basic Information And Sales Area

Table 58: Yamamoto Vinita. Products Portfolio

Table 59: Med-Logix Basic Information And Sales Area

Table 60: Med-Logix. Products Portfolio

Table 61: Thermofield Basic Information And Sales Area

Table 62: Thermofield. Products Portfolio

Table 63: Celsius42 Basic Information And Sales Area

Table 64: Celsius42. Products Portfolio

Table 65: Dongseo Medicare Basic Information And Sales Area

Table 66: Dongseo Medicare. Products Portfolio

Table 67: ThermaSolutions Basic Information And Sales Area

Table 68: ThermaSolutions. Products Portfolio

Table 69: Verthermia Basic Information And Sales Area

Table 70: Verthermia. Products Portfolio

Table 71: Combat Medical Basic Information And Sales Area

Table 72: Combat Medical. Products Portfolio

Table 73: Hydrosun Basic Information And Sales Area

Table 74: Hydrosun. Products Portfolio

Table 75: RanD Biotech Basic Information And Sales Area

Table 76: RanD Biotech. Products Portfolio

Table 77: Shenzhen ET Medical Technology Basic Information And Sales Area

Table 78: Shenzhen ET Medical Technology. Products Portfolio

Table 79: Jiangsu Nova Medical Equipment Basic Information And Sales Area

Table 80: Jiangsu Nova Medical Equipment. Products Portfolio

Table 81: Global Market Value (USD Million) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global Market Value (USD Million) (2025-2032) By Types

Table 84: Global Market Share (%) By Types (2032)

Table 85: Global Market Volume (K) (2025-2032) By Application

Table 86: Global Market Share (%) By Application (2032)

Table 87: Global Market Volume (K) (2025-2032) By Types

Table 88: Global Market Share (%) By Types (2032)

Table 89: Global Hyperthermia Therapy for Cancer Market Value (USD Million) By Region

Table 90: Global Hyperthermia Therapy for Cancer Market Share (%) By Region (2025-2032)

Table 91: North America Market Value (USD Million) (2025-2032) By Country

Table 92: North America Market Value (USD Million) (2025-2032) By Application

Table 93: North America Market Value (USD Million) (2025-2032) By Types

Table 94: Europe Market Value (USD Million) (2025-2032) By Country

Table 95: Europe Market Value (USD Million) (2025-2032) By Application

Table 96: Europe Market Value (USD Million) (2025-2032) By Types

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 98: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 99: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 100: South America Market Value (USD Million) (2025-2032) By Country

Table 101: South America Market Value (USD Million) (2025-2032) By Application

Table 102: South America Market Value (USD Million) (2025-2032) By Types

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 104: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 105: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 106: Global Hyperthermia Therapy for Cancer Market Volume (K) By Region

Table 107: Global Hyperthermia Therapy for Cancer Market Share (%) By Region (2025-2032)

Table 108: North America Market Volume (K) (2025-2032) By Country

Table 109: North America Market Volume (K) (2025-2032) By Application

Table 110: North America Market Volume (K) (2025-2032) By Types

Table 111: Europe Market Volume (K) (2025-2032) By Country

Table 112: Europe Market Volume (K) (2025-2032) By Application

Table 113: Europe Market Volume (K) (2025-2032) By Types

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 115: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 116: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 117: South America Market Volume (K) (2025-2032) By Country

Table 118: South America Market Volume (K) (2025-2032) By Application

Table 119: South America Market Volume (K) (2025-2032) By Types

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 121: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 122: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 123: Research Programs/Design For This Report

Table 124: Key Data Information From Secondary Sources

Table 125: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Hyperthermia Therapy for Cancer Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.15 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Pyrexar Medical; Oncotherm; Andromedic; Yamamoto Vinita; Med-Logix; Thermofield; Celsius42; Dongseo Medicare; ThermaSolutions; Verthermia; Combat Medical; Hydrosun; RanD Biotech; Shenzhen ET Medical Technology; Jiangsu Nova Medical Equipment
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options